Hayriye Şentürk,Selma Pekgör,hümeyra yaka

  • Selma Pekgör: Sağlık Bilimleri Üniversitesi Konya Şehir Hastanesi
  • hümeyra yaka: meram 48 nolu aile sağlığı merkezi
  •  Year : 2025
  •  Vol : 5
  •  Issue : 2
  •  Page : 39-45
Objective: Obesity is a major global health concern due to its rising prevalence and association with chronic diseases. This study aimed to assess the sociodemographic characteristics, anthropometric measurements, biochemical test results, and vitamin levels of patients attending an obesity clinic. Methods: A total of 157 patients seeking medical support for weight loss and meeting the study criteria were included. The study was conducted between October 2016 and December 2018 at the Obesity Clinic of Konya Training and Research Hospital. Participants' sociodemographic data, physical examination findings, and anthropometric measurements, including height, weight, waist circumference (WC), hip circumference (HC), and blood pressure, were recorded. Blood samples were collected after 12 hours of overnight fasting and analyzed on the same day. Results: The study included 139 women (88.50%) and 18 men (11.50%), with a mean age of 35.32±12.61 years. The proportion of married individuals was significantly higher in the obese group (p=0.002), as was the prevalence of chronic diseases (p=0.021). Obesity was less common among individuals with at least a high school education (p<0.001). The obese group had significantly higher values for age (p<0.001), WC (p<0.001), HC (p<0.001), systolic blood pressure (p=0.008), glucose (p<0.001), cholesterol (p=0.010), triglycerides (p=0.001), and LDL (p=0.007). Among obesity grades, age was highest in grade 3 obesity (p=0.003), diastolic blood pressure was higher in grade 2 than in grade 1 (p=0.008), and vitamin D was significantly lower in grade 3 than in both grade 1 (p=0.012) and grade 2 (p=0.037). Insulin resistance was found in 109 participants (69.87%). Those with insulin resistance had higher triglyceride, AST, and ALT levels and lower HDL (p<0.001 for all). Insulin resistance was more common in men (p=0.002) and those with chronic diseases (p=0.003).
Conflict of interest : The authors declare that they have no conflict of interest.

This article is published under the CC BY-NC 4.0 license.
Mevlana Tıp Bilimleri
2025, Vol5, Issue2
E-ISSN: 2757-976X
Received : , Accepted : , Published Online :

References

  1. 1. WHO. Obesity and overweight. 2024. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (Erişim Tarihi: 01.02.2025).
  2. 2. Arroyo-Johnson C, Mincey KD. Obesity epidemiology worldwide. Gastroenterology Clinicsof North America. 2016;45:(4)571-579.
  3. 3. Guevara-Ramírez P, Cadena-Ullauri S, Ruiz-Pozo VA, et al. Genetics, genomics, and diet interactions in obesity in the latin american environment. Front Nutr. 2022;9:1063286.
  4. 4. Sağlık Bakanlığı. Türkiye’de Obezite Cerrahisinin Obezite Tedavisindeki Yeri. 2014. https://shgmargestddb.saglik.gov.tr/Eklenti/36797/0/turkiyede-obezite-cerrahisinin-obezite-tedavisindeki--yeri-30-06-2014pdf.pdf. (Erişim Tarihi: 11.10.2022).
  5. 5. Çolak B, Yormaz S, Ece İ, et al. Morbid Obezite Cerrahisi ve Komplikasyonları. Selçuk Tıp Derg 2016;32(1), 19-22.
  6. 6. Totan B, Yıldıran H, Ayyıldız F. Bağırsak Mikrobiyatası Vücut Ağırlığını Etkiler Mi?. Selcuk University Medical Journal 2019; 35(3).
  7. 7. Kloock S, Ziegler CG, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery? Pharmacology & Therapeutics 2023;251,108549.
  8. 8. Rao PP. Phytochemicals in Obesity Management: Mechanisms and Clinical Perspectives. Current Nutrition Reports 2025;14(1), 1-13.
  9. 9. Malandrino N, Bhat SZ, Alfaraidhy M, et al. Obesity and Aging. Endocrinol. Metab. Clin. N. Am. 2023;52:317–339.
  10. 10. Dogra S, Dunstan DW, Sugiyama T, et al. Active Aging and Public Health: Evidence, Implications, and Opportunities. Annu. Rev. Public Health. 2022;43:439–459.
  11. 11. Tosoratto J, López PJT, López-González ÁA, et al. Association of Shift Work, Sociodemographic Variables and Healthy Habits with Obesity Scales. Life 2024;14(11), 1503.
  12. 12. Dade E, Metz M, Pierre JL, et al. High prevalence of obesity among women in urban Haiti: Findings from a population-based cohort. Front. Public Health 2022;10, 976909.
  13. 13. Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 2003;35,1381–1395.
  14. 14. Wyse CA, Celis Morales CA, Graham N, et al. Adverse metabolic and mental health outcomes associated with shiftwork in a population-based study of 277,168 workers in UK biobank. Ann. Med. 2017;49, 411–420.
  15. 15. Czyz˙-Szypenbejl K, Me˛drzycka-Da˛browska W. The Impact of NightWork on the Sleep and Health of Medical Staff-A Review of the Latest Scientific Reports. J. Clin. Med. 2024;13, 4505.
  16. 16. Koceva A, Herman R, Janez A,et al. Sex-and gender-related differences in obesity: from pathophysiological mechanisms to clinical implications. International journal of molecular sciences 2024;25(13), 7342.
  17. 17. López-González AA, Ramírez Manent JI, Vicente-Herrero M, et al. Prevalence of diabesity in the Spanish working population: Influence of sociodemographic variables and tobacco consumption. An. Sist. Sanit. Navar. 2022;45, e0977.
  18. 18. Trovato A, Tsang T, Manem N, et al. The Impact of Obesity on the Fibrostenosis Progression of Eosinophilic Esophagitis in a U.S. Veterans Cohort. Dysphagia 2023;38, 866–873.
  19. 19. Choi SH, Stommel M, Broman C, et al. Age of Smoking Initiation in Relation to Multiple Health Risk Factors among US Adult Smokers: National Health Interview Survey (NHIS) Data (2006–2018). Behav. Med. 2023;49, 312–319.
  20. 20. Lenártová P, Gažarová M, Mrázová J, et al. Obesity, smoking status and their relationships in selected population groups. Rocz. Panstw. Zakl. Hig. 2021;72, 291–299.
  21. 21. Silveira EA, Mendonca CR, Delpino FM, et al. Sedentary behavior, physical inactivity, abdominal obesity and obesity in adults and older adults: A systematic review and meta-analysis. Clin. Nutr. ESPEN 2022;50, 63–73.
  22. 22. Vanaja K, Vanaja PR, Vjayasree AP. Estimation of Serum biochemical markers in obesity. Journal of Cardiovascular Disease Research 2024;15(5).
  23. 23. Alston MC, Redman LM, Sones, JL. An overview of obesity, cholesterol, and systemic inflammation in preeclampsia. Nutrients 2022;14(10), 2087.
  24. 24. Demirtas MS, Kilicaslan C, Erdal H. Evaluation of vitamin B12 levels among severe obese and obese adolescents. Journal of Investigative Medicine 2024;72(4), 319-325.
  25. 25. Layegh P, Ayati R, Jangjoo A, et al. Gastric bypass surgery in morbid obesity: Influence on thyroid function tests and insulin resistance status. Caspian Journal of Internal Medicine 2024;15(2), 294.
  26. 26. Alshwaiyat NM, Ahmad A, Wan Hassan WMR, et al. Association between obesity and iron deficiency. Experimental and therapeutic medicine 2021;22(5), 1268.
  27. 27. Zhu QR, Kok ED, Bekele HT, et al. Association of serum Folate and Vitamin B12 Concentrations with Obesity in Chinese Children and Adolescents. Biomedical and environmental sciences 2024;37(3), 242-253.
  28. 28. Chapela SP, Martinuzzi ALN, Llobera ND, et al. Obesity and micronutrients deficit, when and how to suplement. Food and Agricultural Immunology 2024;35(1), 2381725.
  29. 29. Biondi B. Subclinical hypothyroidism in patients with obesity and metabolic syndrome: A narrative review. Nutrients 2023;16(1).
  30. 30. Chapela SP, Simancas-Racines A, Ceriani F, et al. Obesity and obesity-related thyroid dysfunction: Any potential role for the very low- calorie ketogenic diet (VLCKD)? Current Nutrition Reports 2024;13(2), 194–213.
  31. 31. Ciarambino T, Crispino P, Guarisco G, et al. Gender differences in insulin resistance: new knowledge and perspectives. Current Issues in Molecular Biology 2023;45(10), 7845-7861.